SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED

Communiqués Shandong Xinhua Pharmaceutical Company Limited

Actions

719 CNE100000411

Temps Différé Hong Kong S.E. Autres places de cotation 08:30:45 05/06/2024			Varia. 5j.	Varia. 1 janv.
5,64 ^HKD	-0,35 %		+0,36 %	-2,77 %

03/06	Les deux médicaments de Shandong Xinhua Pharmaceutical passent l'évaluation de cohérence de l'organisme chinois de réglementation des médicaments	MT
29/05	Le bicarbonate de sodium injectable de Xinhua Pharmaceutical reussit l'evaluation des medicaments generiques en Chine	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Shandong Xinhua Pharmaceutical : Announcement In Relation To Delay In Despatch Of Circular	03/05/21	PU
Shandong Xinhua Pharmaceutical : Appointment of Independent Financial Adviser	20/04/21	PU
Shandong Xinhua Pharmaceutical : Overseas Regulatory Announcement	14/04/21	PU
Shandong Xinhua Pharmaceutical : (1)Proposed Non-public Issuance of New a Shares;(2)Connected Transaction;(3)Application for Whitewash Waiver;and (4)Proposed Amendments to Articles of Association	14/04/21	PU
Shandong Xinhua Pharmaceutical : Unaudited First Quarter Results of 2021	09/04/21	PU
Shandong Xinhua Pharmaceutical : Continuing Connected Transactions In Relation To Shandong Lukang Agreement and China Shandong Agreement	30/03/21	PU
Shandong Xinhua Pharmaceutical : Proposed Amendments of the Articles of Association	30/03/21	PU
Shandong Xinhua Pharmaceutical : Announcement for 2020 Annual Results	30/03/21	PU
Shandong Xinhua Pharmaceutical : Announcement Notice of Board Meeting	26/03/21	PU
Shandong Xinhua Pharmaceutical : Announcement Notice of Board Meeting	18/03/21	PU
Shandong Xinhua Pharmaceutical : Overseas Regulatory Announcement	08/03/21	PU
Shandong Xinhua Pharmaceutical : Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2021	01/03/21	PU
Shandong Xinhua Pharmaceutical : Overseas Regulatory Announcement	21/09/20	PU
Shandong Xinhua Pharmaceutical : Terms of Reference of the Audit Committee under the Board of Directors	21/08/20	PU
Shandong Xinhua Pharmaceutical : Terms of Reference of the Nomination Committee under the Board of Directors	21/08/20	PU
Shandong Xinhua Pharmaceutical : Terms of Reference of the Remuneration and Appraisal Committee under the Board of Directors	21/08/20	PU
Shandong Xinhua Pharmaceutical : Supplemental Announcement In Relation To Continuing Connected Transaction	30/06/20	PU
Shandong Xinhua Pharmaceutical : Announcement Notice of Board Meeting	10/03/20	PU
Shandong Xinhua Pharmaceutical : FURTHER INCREASE IN SHAREHOLDING BY A CONTROLLING SHAREHOLDER	20/11/19	PU
Shandong Xinhua Pharmaceutical : UNAUDITED QUARTERLY RESULTS ANNOUNCEMENT FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2019	28/10/19	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Shandong Xinhua Pharmaceutical Company Limited

Actions

719

CNE100000411

Communiqués

Filtres